Clinical Trials in Cyprus

• EORTC 2237-BCG-QLG: Improvement of Quality of Life through supportive treatments for Endocrine Therapy – related symptoms in patients with e… Not authorised
  2024-513442-10-00 Phase III ER positive HER2 negative breast cancer stages I-II Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europ…
• Efficacy of Ketamine for the Prevention of Relapse in Patients with Opioid-Use Disorders (OUD) Pending
  2025-520843-34-00 Phase II Opioid Use Disorder University of Cyprus
• A Study Comparing the Efficacy and Tolerability of a Combination of Diclofenac and Thiocolchicoside Versus Diclofenac Monotherapy in Patient… Pending
  2025-523153-33-00 Phase III LOW BACK PAIN Verisfield Single Member S.A.
• A study to test the effect of chemotherapy before surgery compared to surgery alone in patients with high risk retroperitoneal sarcoma. Recruiting
  2023-505261-84-00 Phase III Primary high risk leiomyosarcoma or liposarcoma of retroperi… European Organisation For Research And Treatment Of Cancer
• TRITON-PN: A Phase 3 Study to Evaluate the Efficacy and Safety of Nucresiran in Patients with Hereditary Transthyretin Amyloidosis with Poly… Recruiting
  2025-522544-40-00 Phase III Hereditary transthyretin-mediated amyloidosis with polyneuro… Alnylam Pharmaceuticals Inc.
• Artificial Intelligence driven personalisation of radiotherapy and concomitant androgen deprivation therapy for prostate cancer patients Recruiting
  2024-510707-11-00 Phase II Prostate cancer Linac-Pet Scan Opco Limited
• An international, multicenter, randomised, superiority phase III, open label, 2-arm study to investigate distant metastasis free survival wi… Recruiting
  2022-501453-36-00 Phase III Breast cancer European Organisation For Research And Treatment Of Cancer
• A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with active idiopathic inflammat… Recruiting
  2022-502851-79-00 Phase III Active Idiopathic Inflammatory Myopathy (IIM) Argenx
• Study to Assess the Long-Term Safety and Efficacy of ION-682884 in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Recruiting
  2024-511201-32-00 Phase III Hereditary Transthyretin-Mediated Amyloid Polyneuropathy Ionis Pharmaceuticals Inc.
• A study to assess efficacy and safety of efgartigimod PH20 SC in adults with ocular myasthenia gravis Ended
  2024-514133-38-00 Phase III Ocular Myasthenia Gravis Argenx
• A Phase 3 study to evaluate the Efficacy and Safety of Efgartigimod IV in Patients with Acetylcholine Receptor Binding Antibody Seronegative… Ended
  2024-511796-15-00 Phase III Acetylcholine Receptor Binding Antibody Seronegative General… Argenx
• A study to investigate the efficacy and safety of efgartigimod PH20 SC in adult participants with active idiopathic inflammatory myopathy Ended
  2024-512785-33-00 Phase II/III Active Idiopathic Inflammatory Myopathy (IIM) Argenx
• A Multicenter, Adaptive, Randomized, Controlled Trial Platform to Evaluate Safety and Efficacy of Strategies and Treatments for Hospitalized… Ended
  2023-504487-41-00 Phase III COVID-19 University Of Minnesota
• A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Pa… Ended
  2023-508489-14-00 Phase II Solid Tumors F. Hoffmann-La Roche AG
• Lutetium-177-PSMA in Oligo-metastatic Hormone Sensitive Prostate Cancer. Ended
  2023-509881-39-00 Phase II prostate cancer Stichting Radboud University Medical Center
• HELIOS-A: A Phase 3 Global Study to Evaluate the Efficacy and Safety of ALN-TTRSC02 in Patients with Hereditary Transthyretin Amyloidosis Ended
  2023-508365-33-00 Phase III Hereditary Transthyretin Amyloidosis Alnylam Pharmaceuticals Inc.

Showing 1–16 of 16 trials